GE
BMY icon

General Electric’s Bristol-Myers Squibb BMY Stock Holding History

General Electric’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-206,239
Closed -$11M – 206
2013
Q4 		$11M Sell
206,239
-1,519
-0.7% -$77.4K 0.05% 133
2013
Q3 		$9.62M Sell
207,758
-6,315
-3% -$277K 0.05% 138
2013
Q2 		$9.57M Buy
+214,073
New +$9.29M 0.05% 137

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

General Electric's BMY Position: Q1 2014 in Review

General Electric sold out of Bristol-Myers Squibb (BMY) in Q1 2014, closing a stake of 206,239 shares — an estimated $11M sold.

General Electric first reported a position in BMY in Q2 2013 and held it in 3 quarters. The position peaked at $11M in Q4 2013. 1,329 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

  • General Electric reported no remaining Bristol-Myers Squibb position as of Q1 2014 after selling out during the quarter.
  • General Electric sold 206,239 Bristol-Myers Squibb shares in Q1 2014, an estimated $11M.
  • General Electric first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 3 quarters.
  • General Electric's Bristol-Myers Squibb position peaked at $11M in Q4 2013.
  • 1,329 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on General Electric's 13F filing for Q1 2014, filed 13 May 2014.